糖皮质激素通过重塑巨核细胞转录组调控血小板生成
该研究结合体内、离体和体外方法探究糖皮质激素对血小板生成的作用。地塞米松减少小鼠出血并快速增加循环年轻血小板计数,体外刺激巨核细胞前血小板形成和血小板样颗粒释放,该效应可被糖皮质激素受体拮抗剂RU486阻断。全基因组分析显示地塞米松调控超过1000个基因,并诱导Gda表达,抑制鸟嘌呤脱氨酶活性可阻断地塞米松刺激的前血小板形成。
要点
- 地塞米松减少小鼠出血并快速增加循环年轻血小板计数。
- 糖皮质激素通过糖皮质激素受体依赖机制刺激前血小板形成。
- 地塞米松诱导Gda表达,鸟嘌呤脱氨酶活性参与该效应。
核心结论
- 研究结果将糖皮质激素鉴定为血小板生成的新调控因子。
研究设计与样本
- 研究结合体内、离体和体外方法探究糖皮质激素对血小板生成的作用。
主要发现
- 地塞米松减少小鼠出血并快速增加循环年轻血小板计数。
- 体外糖皮质激素处理刺激巨核细胞前血小板形成和血小板样颗粒释放。
- 该效应可被糖皮质激素受体拮抗剂RU486阻断,提示糖皮质激素受体依赖机制。
- 全基因组分析显示地塞米松调控超过1000个与多种细胞功能相关的基因,包括显著的细胞质和细胞骨架重组。
- 地塞米松和其他糖皮质激素诱导Gda(编码鸟嘌呤脱氨酶的基因)表达,抑制鸟嘌呤脱氨酶酶活性可阻断地塞米松刺激的前血小板形成。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glucocorticoids are widely known for their immunomodulatory action. Their synthetic analogs are used to treat several autoimmune diseases, including immune thrombocytopenia. However, their efficacy and mechanisms of action in immune thrombocytopenia are not fully understood. OBJECTIVES: To investigate the mechanism of glucocorticoid actions on platelet production. METHODS: The actions of glucocorticoids on platelet production were studied combining in vivo, ex vivo and in vitro approaches. RESULTS: Dexamethasone reduced bleeding in mice and rapidly increased circulating young platelet counts. In vitro glucocorticoid treatment stimulated proplatelet formation by megakaryocytes and platelet-like particle release. This effect was blocked by glucocorticoid receptor antagonist RU486, indicating a glucocorticoid receptor-dependent mechanism. Genome-wide analysis revealed that dexamethasone regulates the expression of >1000 genes related to numerous cellular functions, including predominant cytoplasm and cytoskeleton reorganization. Dexamethasone and other glucocorticoids induced the expression of Gda (the gene encoding guanine deaminase), which has been reported to have a role in dendrite development. Inhibition of guanine deaminase enzymatic activity blocked dexamethasone stimulation of proplatelet formation, implicating a critical role for this enzyme in glucocorticoid-mediated platelet production. CONCLUSION: Our findings identify glucocorticoids as new regulators of thrombopoiesis.
引用
- Grodzielski M, Cidlowski JA. Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome. J Thromb Haemost. 2023. PMID: 37336437. doi:10.1016/j.jtha.2023.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。